
It was exactly the kind of medical mystery that has yielded to genome sequencing. From age 7, Ricky Ramon’s body had sprouted tumor after (non-cancerous) tumor: in his heart and his pituitary gland, his adrenal glands and his thyroid. Those symptoms seemed to fit a rare genetic disease called Carney complex, which is caused by mutations in the PRKAR1A gene on chromosome 17. But standard DNA sequencing found no disease-causing glitches there or anywhere.
When Ricky was 25, however, researchers at the Stanford University School of Medicine used a cutting-edge technology called long-read sequencing to crack the case. It is the first time that long read, whole genome sequencing has been used to diagnose a patient, Stanford genetics professor Dr. Euan Ashley and his colleagues reported on Thursday in the journal Genetics in Medicine.
What is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
So very interesting and inspiring. Thsnk you.
I really like the stories you share which leads to more Knowledge in the biology field.